Core Scientific, Inc. Common Stock Cash Flow Reinvestment Rate

Latest as of March 2026: 1.56x

Core Scientific, Inc. Common Stock cash flow reinvestment rate. Core Scientific, Inc. Common Stock (CORZ) has a Cash Flow Reinvestment Rate of 1.56x as of March 2026, reinvesting $389.23 Million (capex $389.23 Million ) from operating cash flow of $249.88 Million. See CORZ financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

1.56x
(Capex + Investments) / Operating CF

Total Reinvested

$389.23 Million
Capex + Investments

Operating Cash Flow

$249.88 Million
USD

Capital Expenditures

$389.23 Million
USD

Cash Flow Reinvestment Rate of Core Scientific, Inc. Common Stock (2022–2025)

Cash flow reinvestment rate of Core Scientific, Inc. Common Stock from 2022 to 2025. Historical reinvestment intensity for Core Scientific, Inc. Common Stock across 4 annual periods. Explore how well can Core Scientific, Inc. Common Stock service its debt to assess how comfortably operating cash covers total debt obligations.

Core Scientific, Inc. Common Stock Cash Flow Reinvestment Rate by Year (2022–2025)

Core Scientific, Inc. Common Stock cash flow reinvestment rate by year from 2022 to 2025. Year-by-year capital reinvestment analysis for Core Scientific, Inc. Common Stock. For the full cash flow conversion analysis, see cash flow conversion of Core Scientific, Inc. Common Stock.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 2.62x $729.00 Million $278.25 Million $729.00 Million ▼ -40.9%
2024 4.43x $190.15 Million $42.90 Million $94.96 Million ▲ +1406.7%
2023 0.29x $19.16 Million $65.11 Million $16.16 Million ▼ -90.1%
2022 2.99x $612.51 Million $205.19 Million $601.66 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow